Phio Pharmaceuticals Corp. (PHIO)

NASDAQ: PHIO · IEX Real-Time Price · USD

0.640

+0.005 (0.77%)

At close: Apr 19, 2024, 3:57 PM

0.618

-0.022 (-3.50%)

After-hours: Apr 19, 2024, 7:59 PM EDT

Phio Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2010
Revenue	0	0	0	0	0.02	0.14	0.02	0.02	0.03	0.07	Upgrade
Revenue Growth (YoY)	-	-	-	-	-84.78%	820.00%	-21.05%	-44.12%	-52.11%	-82.21%	Upgrade
Gross Profit	0	0	0	0	0.02	0.14	0.02	0.02	0.03	0.07	Upgrade
Selling, General & Admin	4.37	4.45	4.63	5.08	4.71	3.18	4.01	3.62	3.35	3.22	Upgrade
Research & Development	6.33	7.01	8.89	3.72	4.3	4.33	5.37	5.42	6.93	5.68	Upgrade
Other Operating Expenses	0.13	0	0	0	0	0	4.7	0	0	0	Upgrade
Operating Expenses	10.82	11.46	13.51	8.79	9.01	7.5	14.08	9.03	10.27	8.9	Upgrade
Operating Income	-10.82	-11.46	-13.51	-8.79	-8.99	-7.36	-14.06	-9.02	-10.24	-8.83	Upgrade
Interest Expense / Income	0	0	0	0	0	0	0	-0.02	0	0	Upgrade
Other Expense / Income	0	0.02	-0.22	-	-0.08	-0	0.01	-0.01	-0.01	-0.03	Upgrade
Pretax Income	-10.83	-11.48	-13.29	-8.79	-8.91	-7.36	-14.07	-8.99	-10.22	-8.8	Upgrade
Income Tax	0	0	0	0	0	0	-1.62	0	0	0	Upgrade
Net Income	-10.83	-11.48	-13.29	-8.79	-8.91	-7.36	-12.45	-8.99	-10.22	-8.8	Upgrade
Preferred Dividends	0	0	0	0	0	0	0	2.08	0.21	4.13	Upgrade
Net Income Common	-10.83	-11.48	-13.29	-8.79	-8.91	-7.36	-12.45	-11.07	-10.43	-12.93	Upgrade
Shares Outstanding (Basic)	2	1	1	0	0	0	0	0	0	0	Upgrade
Shares Outstanding (Diluted)	2	1	1	0	0	0	0	0	0	0	Upgrade
Shares Change	83.32%	6.30%	179.70%	895.49%	259.76%	212.01%	234.74%	35.72%	203.63%	58.97%	Upgrade
EPS (Basic)	-5.20	-10.10	-12.43	-23.04	-231.96	-689.52	-3643.20	-10830.61	-13860.02	-52140.07	Upgrade
EPS (Diluted)	-5.20	-10.10	-12.43	-23.04	-231.96	-689.52	-3643.20	-10830.61	-13860.02	-52140.07	Upgrade
Free Cash Flow	-10.75	-12.25	-11.91	-8.82	-8.72	-7.53	-9.72	-7.76	-7.37	-7.84	Upgrade
Free Cash Flow Per Share	-5.16	-10.78	-11.14	-23.07	-227.00	-705.00	-2840.53	-7595.89	-9791.70	-31626.88	Upgrade
Gross Margin	-	-	-	-	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	Upgrade
Operating Margin	-	-	-	-	-42795.24%	-5336.23%	-93746.67%	-47447.37%	-30108.82%	-12430.99%	Upgrade
Profit Margin	-	-	-	-	-42419.05%	-5333.33%	-83013.33%	-58257.89%	-30682.35%	-18211.27%	Upgrade
Free Cash Flow Margin	-	-	-	-	-41509.52%	-5452.90%	-64780.00%	-40863.16%	-21688.24%	-11043.66%	Upgrade
EBITDA	-10.64	-11.29	-13.1	-8.61	-8.73	-7.28	-14	-8.96	-10.15	-8.71	Upgrade
EBITDA Margin	-	-	-	-	-41580.95%	-5274.64%	-93353.33%	-47136.84%	-29841.18%	-12271.83%	Upgrade
Depreciation & Amortization	0.18	0.19	0.19	0.18	0.18	0.08	0.07	0.05	0.08	0.09	Upgrade
EBIT	-10.83	-11.48	-13.29	-8.79	-8.91	-7.36	-14.07	-9.01	-10.22	-8.8	Upgrade
EBIT Margin	-	-	-	-	-42419.05%	-5333.33%	-93820.00%	-47415.79%	-30067.65%	-12394.37%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).